Details van artikel 580 van 592 gevonden artikelen
481TiP Checkmate 722: A phase 3 trial of nivolumab with chemotherapy or ipilimumab vs chemotherapy in epidermal growth factor receptor (EGFR)-mutation, T790M-negative stage IV or recurrent non-small cell lung cancer (NSCLC) after EGFR tyrosine kinase inhibitor (TKI) therapy
Titel:
481TiP Checkmate 722: A phase 3 trial of nivolumab with chemotherapy or ipilimumab vs chemotherapy in epidermal growth factor receptor (EGFR)-mutation, T790M-negative stage IV or recurrent non-small cell lung cancer (NSCLC) after EGFR tyrosine kinase inhibitor (TKI) therapy
Auteur:
Nakagawa, K. Yang, J.C.-H. Park, K. Ohe, Y. Wu, Y.-L. Gainor, J. Blackwood-Chirchir, A. Yang, R. Chang, I.-F. Mok, T.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 27 () nr. S9 pagina's ix154-ix155
Jaar:
2016
Inhoud:
Uitgever:
European Society for Medical Oncology
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 580 van 592 gevonden artikelen